Literature DB >> 12297329

Adenoviral inhibitors of apoptotic cell death.

Adrienne L McNees1, Linda R Gooding.   

Abstract

Adenoviruses (Ads) are endemic in the human population and the well-studied group C Ads typically cause an acute infection in the respiratory epithelium. A growing body of evidence suggests that these viruses also establish a persistent infection. The Ad genome encodes several proteins that counteract the host anti-viral mechanisms, which function to limit viral infections. This review describes the adenovirus immuno-regulatory proteins and how they function to block apoptosis of infected cells. In addition to facilitating the successful completion of the viral replication cycle and spread of progeny virus, these functions may help maintain the virus in a persistent state.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297329     DOI: 10.1016/s0168-1702(02)00122-3

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

1.  Adenovirus E3-6.7K protein is required in conjunction with the E3-RID protein complex for the internalization and degradation of TRAIL receptor 2.

Authors:  Drew L Lichtenstein; Konstantin Doronin; Karoly Toth; Mohan Kuppuswamy; William S M Wold; Ann E Tollefson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Genetic identification of adenovirus type 5 genes that influence viral spread.

Authors:  T Subramanian; S Vijayalingam; G Chinnadurai
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions.

Authors:  Mark Windheim; Jennifer H Southcombe; Elisabeth Kremmer; Lucy Chaplin; Doris Urlaub; Christine S Falk; Maren Claus; Janine Mihm; Myles Braithwaite; Kevin Dennehy; Harald Renz; Martina Sester; Carsten Watzl; Hans-Gerhard Burgert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

4.  Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.

Authors:  Zsolt Ruzsics; Markus Wagner; Andrea Osterlehner; Jonathan Cook; Ulrich Koszinowski; Hans-Gerhard Burgert
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism.

Authors:  Wulf Schneider-Brachert; Vladimir Tchikov; Oliver Merkel; Marten Jakob; Cora Hallas; Marie-Luise Kruse; Peter Groitl; Alexander Lehn; Eberhard Hildt; Janka Held-Feindt; Thomas Dobner; Dieter Kabelitz; Martin Krönke; Stefan Schütze
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

6.  The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease.

Authors:  Amit Srivastava; Philipp Henneke; Alberto Visintin; Sarah C Morse; Victoria Martin; Claire Watkins; James C Paton; Michael R Wessels; Douglas T Golenbock; Richard Malley
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  The human papillomavirus 16 E6 protein can either protect or further sensitize cells to TNF: effect of dose.

Authors:  M Filippova; T A Brown-Bryan; C A Casiano; P J Duerksen-Hughes
Journal:  Cell Death Differ       Date:  2005-06-03       Impact factor: 15.828

8.  The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis.

Authors:  Adrienne L McNees; C T Garnett; Linda R Gooding
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis.

Authors:  Vera L Tarakanova; William S M Wold
Journal:  Virus Res       Date:  2009-10-23       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.